Nevirapine Patent Expiration
Nevirapine is Used for managing HIV-1 infection through once-daily administration. It was first introduced by Boehringer Ingelheim Pharmaceuticals Inc
Nevirapine Patents
Given below is the list of patents protecting Nevirapine, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Viramune Xr | US8460704 | Extended release formulation of nevirapine | Mar 12, 2029 | Boehringer Ingelheim |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Nevirapine's patents.
Latest Legal Activities on Nevirapine's Patents
Given below is the list recent legal activities going on the following patents of Nevirapine.
Event | Date | Patent/Publication |
---|---|---|
![]() | ||
Payment of Maintenance Fee, 8th Year, Large Entity | 21 Sep, 2020 | US8460704 |
Post Issue Communication - Certificate of Correction | 05 Feb, 2015 | US8460704 |
Email Notification | 13 Sep, 2014 | US8460704 |
Mail-Record a Petition Decision of Granted for Patent Term Adjustment after Allowance | 10 Sep, 2014 | US8460704 |
Record a Petition Decision of Granted for Patent Term Adjustment after Allowance | 09 Sep, 2014 | US8460704 |
Adjustment of PTA Calculation by PTO | 05 Sep, 2014 | US8460704 |
Petition Entered | 14 Jun, 2013 | US8460704 |
Recordation of Patent Grant Mailed | 11 Jun, 2013 | US8460704 |
Patent Issue Date Used in PTA Calculation | 11 Jun, 2013 | US8460704 |
Email Notification | 23 May, 2013 | US8460704 |
Coming Soon
Patent Strength Analyzer
![](/_nuxt/img/PatentAnalyzerAd.722976d.jpg)
YesNo
Thank you for your response 🥳
Nevirapine Generics
Several generic applications have been filed for Nevirapine. The first generic version for Nevirapine was by Cipla Ltd and was approved on May 22, 2012. And the latest generic version is by Macleods Pharmaceuticals Ltd and was approved on Jan 14, 2019.
Given below is the list of companies who have filed for Nevirapine generic.
1. MYLAN PHARMS INC
Mylan Pharmaceuticals Inc has filed for 1 generic for Nevirapine. Given below are the details of the strengths of this generic introduced by Mylan Pharms Inc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
200MG | tablet | Prescription | ORAL | AB | May 22, 2012 |
2. CIPLA
Cipla Ltd has filed for 3 different strengths of generic version for Nevirapine. Given below are the details of the strengths of this generic introduced by Cipla.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
200MG | tablet | Prescription | ORAL | AB | May 22, 2012 |
400MG | tablet, extended release | Discontinued | ORAL | N/A | Oct 15, 2015 |
50MG/5ML | suspension | Prescription | ORAL | AA | Aug 3, 2017 |
3. MYLAN LABS
Mylan Laboratories Ltd has filed for 1 generic for Nevirapine. Given below are the details of the strengths of this generic introduced by Mylan Labs.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
200MG | tablet | Discontinued | ORAL | N/A | May 22, 2012 |
4. MYLAN
Mylan Pharmaceuticals Inc has filed for 2 different strengths of generic version for Nevirapine. Given below are the details of the strengths of this generic introduced by Mylan.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
400MG | tablet, extended release | Prescription | ORAL | AB | Oct 27, 2014 |
100MG | tablet, extended release | Discontinued | ORAL | N/A | Nov 9, 2015 |
5. MACLEODS PHARMS LTD
Macleods Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Nevirapine. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
400MG
(reference standard) | tablet, extended release | Prescription | ORAL | AB | Oct 6, 2017 |
200MG
(reference standard) | tablet | Prescription | ORAL | AB | Jan 14, 2019 |
6. SANDOZ
Sandoz Inc has filed for 1 generic for Nevirapine. Given below are the details of the strengths of this generic introduced by Sandoz.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
400MG | tablet, extended release | Prescription | ORAL | AB | Apr 3, 2014 |
7. HETERO LABS LTD III
Hetero Labs Ltd Unit Iii has filed for 1 generic for Nevirapine. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd Iii.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
200MG | tablet | Prescription | ORAL | AB | May 22, 2012 |
8. APOTEX INC
Apotex Inc has filed for 1 generic for Nevirapine. Given below are the details of the strengths of this generic introduced by Apotex Inc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
200MG | tablet | Discontinued | ORAL | N/A | May 22, 2012 |
9. STRIDES PHARMA
Strides Pharma Global Pte Ltd has filed for 1 generic for Nevirapine. Given below are the details of the strengths of this generic introduced by Strides Pharma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
200MG | tablet | Prescription | ORAL | AB | May 22, 2012 |
10. MICRO LABS LTD
Micro Labs Ltd has filed for 1 generic for Nevirapine. Given below are the details of the strengths of this generic introduced by Micro Labs Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
200MG | tablet | Prescription | ORAL | AB | May 22, 2012 |
11. TECH ORGANIZED
Technology Organized Llc has filed for 3 different strengths of generic version for Nevirapine. Given below are the details of the strengths of this generic introduced by Tech Organized.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
200MG | tablet | Discontinued | ORAL | N/A | May 22, 2012 |
100MG | tablet, extended release | Discontinued | ORAL | N/A | Jul 31, 2017 |
400MG | tablet, extended release | Discontinued | ORAL | N/A | Jul 31, 2017 |
12. AUROBINDO PHARMA
Aurobindo Pharma Ltd has filed for 2 different strengths of generic version for Nevirapine. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
100MG | tablet, extended release | Discontinued | ORAL | N/A | Nov 23, 2016 |
400MG | tablet, extended release | Discontinued | ORAL | N/A | Feb 28, 2017 |
13. ALVOGEN
Alvogen Inc has filed for 2 different strengths of generic version for Nevirapine. Given below are the details of the strengths of this generic introduced by Alvogen.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
400MG | tablet, extended release | Discontinued | ORAL | N/A | Jul 10, 2015 |
100MG | tablet, extended release | Discontinued | ORAL | N/A | Nov 9, 2015 |
14. PRINSTON INC
Prinston Pharmaceutical Inc has filed for 1 generic for Nevirapine. Given below are the details of the strengths of this generic introduced by Prinston Inc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
200MG | tablet | Discontinued | ORAL | N/A | May 22, 2012 |
15. APOTEX
Apotex Inc has filed for 1 generic for Nevirapine. Given below are the details of the strengths of this generic introduced by Apotex.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
400MG | tablet, extended release | Discontinued | ORAL | N/A | Apr 3, 2014 |
16. AUROBINDO
Aurobindo Pharma Ltd has filed for 2 different strengths of generic version for Nevirapine. Given below are the details of the strengths of this generic introduced by Aurobindo.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
200MG | tablet | Prescription | ORAL | AB | May 22, 2012 |
50MG/5ML
(reference standard) | suspension | Prescription | ORAL | AA | May 22, 2012 |